Benchmark analyst Raymond Myers says he confirmed with management that Exact Sciences recently secured insurance coverage with United Healthcare (UNH) and Aetna (AET). Progression from contracting to coverage "was much faster" than the 9-12 months management had forecast, Myers tells investors in a research note. He expects the added coverage to support accelerated Cologuard traction starting in the current quarter. Myers raised his Q4 Cologuard test forecast to over 150,000 from 140,000 as well as next year's revenue estimate to $340.6M from $320.7M. He keeps a Buy rating and $50 price target on Exact Sciences.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here